Panic Disorder
📧 Sign up to get email alerts when something new happens for Panic Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-08-02FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2007-08-01FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC. The action pertai…
-
FDA approval · 2007-07-25FDA Approved: PAROXETINE — Original Application (NorthStar Rx LLC)
FDA approves NorthStar Rx LLC's original ANDA for paroxetine hydrochloride (generic paroxetine).
-
FDA approval · 2007-07-12FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for venlafaxine hydrochloride submitted by Teva Pharmaceuticals USA, Inc. The approval updates t…
-
FDA approval · 2007-07-09FDA Approved: CLONAZEPAM — Supplemental Application (Solco Healthcare LLC)
FDA granted a supplemental approval for clonazepam from Solco Healthcare LLC under ANDA077856.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-06-25FDA Approved: IMIPRAMINE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for imipramine hydrochloride from Strides Pharma Science Limited. The approval covers the continued …
-
FDA approval · 2007-05-24FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for fluoxetine, authorizing changes to the product's labeling.
-
FDA approval · 2007-04-30FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (ScieGen Pharmaceuticals Inc)
FDA approved ScieGen Pharmaceuticals Inc.'s sertraline hydrochloride as a generic under an Original Abbreviated New Drug Application for the…
-
CLINICAL_TRIALS research · 2007-04-27Clinical Trial Update: Study of Virtual Reality Therapy and Cognitive Behavior Therapy in Panic Disorder With Agoraphobia [NA]
This document reports on a clinical trial comparing virtual reality therapy to cognitive behavioral therapy for panic disorder with agorapho…
-
CLINICAL_TRIALS research · 2007-04-05Clinical Trial Update: Panic Disorder and Cardiac Risk [NA]
A clinical trial update on panic disorder and potential cardiac risk; the current status is UNKNOWN.
-
FDA approval · 2007-03-15FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
The FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2007-03-07FDA Approved: PAROXETINE — Original Application (Zydus Lifesciences Limited)
FDA approves Zydus Lifesciences Limited's original application for paroxetine hydrochloride tablets (generic paroxetine). This approval prov…
-
FDA approval · 2007-02-13FDA Approved: ALPRAZOLAM EXTENDED RELEASE — Original Application (Actavis Pharma, Inc.)
FDA approved a generic alprazolam extended-release tablet (Actavis) via Original Application, adding another market option for anxiety and p…
-
FDA approval · 2007-02-09FDA Approved: FLUOXETINE — Original Application (Lannett Company, Inc.)
FDA approved the original application for a generic fluoxetine hydrochloride product from Lannett Company, Inc.
-
FDA approval · 2007-02-06FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' sertraline hydrochloride as a generic drug via an Original ANDA approval.
-
FDA approval · 2007-02-06FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved an Original Application (ANDA) for sertraline hydrochloride from Quallent Pharmaceuticals Health LLC, a generic version of sert…
-
FDA approval · 2007-02-06FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
The FDA approved an original application for a generic sertraline hydrochloride product from Aurobindo Pharma Limited.
-
FDA approval · 2007-02-05FDA Approved: PAROXETINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application from Apotex Corp. for paroxetine hydrochloride as a generic product. Paroxetine is used to treat maj…
-
FDA approval · 2007-01-25FDA Approved: FLUOXETINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for fluoxetine filed by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2006-11-17FDA Approved: FLUOXETINE — Supplemental Application (TIME CAP LABORATORIES, INC.)
The FDA approved a supplemental application for a fluoxetine hydrochloride product from Time Cap Laboratories, Inc., approving this generic …
-
CLINICAL_TRIALS trial_result · 2006-09-29Clinical Trial Update: ELB139 Given Orally to Patients With Concurrent Panic Disorder, Challenged by CO2 Inhalation After a Single Dose and One Week of Treatment [Phase 2]
A Phase 2 trial evaluating the oral ELB139 in patients with panic disorder under CO2 challenge after a single dose and one week of treatment…
-
FDA label_change · 2006-09-20FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company, approving changes to the …
-
FDA approval · 2006-09-14FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2006-09-11Clinical Trial Update: A Study of Risperidone Monotherapy in Bipolar Anxiety [Phase 4]
Phase 4 trial of risperidone monotherapy for bipolar anxiety has completed, examining efficacy in bipolar disorder with co-occurring panic o…
-
FDA approval · 2006-08-22FDA Approved: PAXIL — Supplemental Application (Apotex Corp)
The FDA approved a supplemental application for Paxil (paroxetine hydrochloride) submitted by Apotex Corp.